A Molecular Profile Monitoring the Advancement of Non-Muscle Invasive Bladder Carcinoma - Takeaways - MDSpire

A Molecular Profile Monitoring the Advancement of Non-Muscle Invasive Bladder Carcinoma

  • By

  • Giuseppe Cesta

  • Cinzia Zolfanelli

  • Vincenzo Lauciello

  • Vincenzo Lorusso

  • Ferdinando Di Giacomo

  • Pellegrino Mazzone

  • Teresa D’Amore

  • Giuseppina Di Paola

  • Daniele Bravoco

  • Geppino Falco

  • Claudia Sabato

  • April 20, 2026

  • 0 min

Share

  • 1

    Bladder cancer is the ninth most common cancer globally, with higher incidence rates in developed countries due to lifestyle and environmental factors.

  • 2

    Non-muscle-invasive bladder cancer (NMIBC) is primarily diagnosed through cystoscopy and urine cytology, with imaging methods aiding in evaluation.

  • 3

    Therapeutic strategies for NMIBC include transurethral resection and adjuvant treatments like BCG, while muscle-invasive bladder cancer (MIBC) requires more aggressive interventions.

  • 4

    NMIBC has a high recurrence rate of 50-70% and progression rate of 10-30%, highlighting the need for effective monitoring and treatment strategies.

  • 5

    Genomic and transcriptomic profiling of bladder cancer reveals distinct genetic alterations that may enhance early detection and personalized treatment approaches.

Original Source(s)

A Molecular Profile Monitoring the Advancement of Non-Muscle Invasive Bladder Carcinoma

  • by Giuseppe Cesta, Cinzia Zolfanelli, Vincenzo Lauciello, Vincenzo Lorusso, Ferdinando Di Giacomo, Pellegrino Mazzone, Teresa D’Amore, Giuseppina Di Paola, Daniele Bravoco, Geppino Falco, Claudia Sabato

  • April 20, 2026

Related Content

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report